<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Beta-2-GPI is a 50 kDa <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> which is known to be a serum co-factor, with a role in determining the binding of pathogenic anticardiolipin antibodies to <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Immunization of naive mice with beta-2-GPI resulted in elevated levels of antibodies directed against negatively charged <z:chebi fb="1" ids="16247">phospholipids</z:chebi> (<z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, phosphotidylserine, phosphatidylinositol) </plain></SENT>
<SENT sid="2" pm="."><plain>The presence of increased titres of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in the sera of the mice was later followed by <z:hpo ids='HP_0003645'>prolonged activated partial thromboplastin time</z:hpo> (APTT), <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, and when the mice were mated, by a high percentage of <z:e sem="disease" ids="C0015951" disease_type="Disease or Syndrome" abbrv="">fetal resorptions</z:e> in the uterus </plain></SENT>
<SENT sid="3" pm="."><plain>These data point to the ability of beta-2-GPI to induce pathogenic anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibodies following active immunization </plain></SENT>
</text></document>